Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 173-178

  Gavaldà, Joan ^a,b   Cardona, Pere Joan ^a   Almirante, Benito ^a   Capdevila, Josep Antón ^a   Laguarda, Montserrat ^a   Pou, Leonor ^b   Crespo, Ernesto ^b   Pigrau, Carles ^a   Pahissa, Albert ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030052438     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.173     Document Type: Article

References (40)

1. Anhalt, J. P. 1985. Antimicrobial assays, p. 691-729. In J. A. Washington II (ed.), Laboratory procedures in clinical microbiology. Springer-Verlag. New York.
2. Anhalt, J. P., and J. A. Washington II. 1985. Bactericidal tests, p. 731-745. In J. A. Washington II (ed.), Laboratory procedures in clinical microbiology. Springer-Verlag, New York.
3. Bamonte, F., S. Dionisotti, M. Gamba, E. Ongini, A. Arpini, and G. Melone. 1990 Relation of dosing regimen to aminoglycoside ototoxicity: evaluation of auditory damage in the guinea pig Chemotherapy (Basel) 36:41-50.
4. Bisno, A. L., W. E. Dismukes, D. T. Durack, E. L. Kaplan, A. W. Karchmer, D. Kaye, S. H. Rahimtoola, M. A. Sande, J. P. Sanford, C. Watanakunakorn, and W. R. Wilson. 1989. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA 261: 1471-1477.
5. Blatter, M., U. Fluckiger, J. Entenza, M. P. Glauser, and P. Francioli. 1993. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37:1971-1976.
6. Chambers, H. F., S. Kennedy, M. Fournier, M. S. Rouse, and W. R. Wilson. 1990. Ceftriaxone (C) vs. procame penicillin (P) alone and with gentamicin (G) in viridans streptococcal aortic valve endocarditis in rabbits, abstr. 701. p 203. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
7. Crémieux, A. C., A. Saleh-Mghir, J. M. Vallois, M. Muffat-Jolly, C. Devine, J. J. Pocidalo, and C. Carbon. 1993. Influence of the pre-treatment duration of infection on the efficacies of various antibiotic regimens in experimental streptococcal endocarditis J. Antimicrob. Chemother. 32:843-852.
8. Dorscher, C. W., B. M. Tallan, M. S. Rouse, J. M. Steckelberg, H. C. Chambers, and W. R. Wilson. 1990. Effect of gentamicin dosing interval on ceftriaxone or penicillin treatment (Rx) of viridans streptococcal (VS) experimental (exp) endocarditis (E), abstr. 700, p 203. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Durack, D. T., and P. B. Beeson, 1972. Experimental bacterial endocarditis I. Colonisation of a sterile vegetation. Br J. Exp. Pathol. 53:44-49.
10. Eliopoulos, G. M., and R. C. Moellering. 1991. Laboratory methods used to assess the activity of antimicrobial combinations, p. 434-449. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins Co., Baltimore.
11. Fantin, B., and C. Carbon. 1990. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother 34:2387-2391.
12. Fluckiger, U., P. Moreillon, J. Blaser, M. Bickle, M. P. Glauser, and P. Francioli. 1994. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob. Agents Chemother 38:2846-2849
13. Flückiger, U., C. Segessenmann, and A. U. Gerber. 1991. Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model. Antimicrob. Agents Chemother. 35:1905-1910.
14. Francioli, P., W. Ruch, D. Stambulian, and the International Infective Endocarditis Study Group. 1993 Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days, 11. In Program and abstracts of the 2nd International Symposium on Modern Concepts in Endocarditis.
15. Fuursted, K. 1987. Comparison of the post-antibiotic effect of Streptococcus faecalis and Streptococcus faecium with ampicillin alone or combined with streptomycin: studies on a novel type of antimicrobial interaction. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 95:251-357.
16. Fuursted, K. 1988. Evaluation of the combination effects of ampicillin or vancomycin combined with streptomycin, gentamicin, tobramycin or netilmicin against enterococci. Acta Pathol. Microbiol. Immunol. Scand. 97:23-26
17. Garrison, P., and L. R. Freedman. 1970. Experimental endocarditis. I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in right side of the heart. Yale J. Biol. Med. 42:394-410.
18. Gavalda, J., P. J. Cardona, A. Pahissa, B. Almirante, E. Crespo, L. Pou, J. M. Martinez-Vasquez, J. Steckelberg, M. Rouse, and W. R. Wilson. 1993. Effect of Gentamicin (G) dosing interval on G plus ampicillin (A) treatment (Rx) of enterococcal experimental endocarditis, abstr. 156. p. 148. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington. D C.
19. Gavaldà, J., A. Pahissa, B. Almirante, M. Laguarda, E. Crespo, L. Pou, and F. Fernández. 1995. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob. Agenls Chemother. 39:2098-2103.
20. Gerber, A. U., H. P. Brugger, C. Feller, T. Stritzko, and B. Stalder. 1986. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153:90-97
21. Gerber, A. U., S. Kozak, C. Segessenmann, U. Fluckiger, T. Bangerter, and U. Greter. 1989. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a manadapted neutropenic animal model Eur. J Clin. Microbiol Infect. Dis. 8:233-237
22. Gerber, A. U., T. Stritzko, C. Segessenmann, and B. Stalder. 1991. Simulation of human pharmacokinetics profiles in mice, and impact on antimiciobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model. Scand. J. Infect Dis 74:195-230
23. Hessen, M. T., P. G. Pistakis, and M. E. Levison. 1989. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus, faecalis in vitro and in vivo Antimicrob Agents Chemother. 33:608-611.
24. Kapusnik, J. E., C. J. Hackbarth, H. F. Chambers, T. Carpenter, and M. A. Sande. 1988. Single, large, daily dosing versus intermittent dosing of tobiamycin for treating experimental Pseudomonas pneumonia. J. Infect Dis 158:7-12.
25. Legget, J. E., B. Fantin, S. Ebert, K. Totsuka, W. Calame, H. Mattie, and W. A. Craig. 1989 Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis 159:281-292.
26. Maller, R., H. Ahrne, T. Eilard, I. Eriksson, I. Lausen, and the Scandinavian Amikacin Once Daily Study Group. 1991 Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses J. Antimicrob. Chemother. 27(Suppl. C):121-128.
27. Mizen, L., G. Woodnutt, I. Kernutt, and E. Catherall. 1989. Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis. Antimicrob. Agents Chemother. 33:693-699
28. Moellering, R. C., Jr. 1995. Enterococcus species. Streptococcus bovis, and Leuconostoc species, p 1826-1860. In G. E. Mandell, J. E. Bennet, and R. Dolin (ed), Principles and practice of infectious diseases, 4th ed. Churchill and Livingstone, Inc., New York.
29. Norrby, S. R., T. O'Reilly, and O. Zak. 1993. Efficacy of antimicrobial agent treatment in relation to treatment regimen: experimental models and clinical evaluation. J. Antimicrob. Chemother. 21(Suppl. D):41-54.
30. Norris, S., C. H. Nightingale, and G. L. Mandell. 1990 Tables of antimicrobial agent pharmacology, p. 434-460. In G. E. Mandell, R G. Douglas, and J. E Bennet (ed.). Principles and practice of infectious diseases. 3rd ed Churchill and Livingstone, Inc , New York.
31. Olier, B., G. Viotte, J. P. Morin, and J. P. Fillastre. 1983. Influence of dosage regimen on experimental tobramycin nephrotoxicity. Chemotherapy (Basel) 29:385-394.
32. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis II Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-213
33. Prins. J. M., H. R. Büller, E. J. Kuijper, R. A. Tange, and P. Speelman. 1993 Once versus thrice daily gentamicin in patients with serious infections. Lancet 341:335-338
34. Saleh-Mghir, A., A.-C. Crémieux, J.-M. Vallois. M. Muffat-Joly, C. Devine, and C. Carbon. 1992. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis. Antimicrob. Agents Chemother 36:2403-2407.
35. Sturm, A. W. 1989. Netilmicin in the treatment of gram-negative bacteremia single daily versus multiple daily dosage. J. Infect. Dis. 159:931-937.
36. ter Braak, E. W., P. J. de Vries, K. P. Bouter, S. G. van der Vegt, G. C. Dorrestein, J. W. Nortier, A. van Dijk, R. P. Verkooyen, and H. A. Verbrugh. 1990. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmiein plus ceftriaxone. Am. J. Med 89:58-66
37. Tulkens, P. M. 1991. Pharmacokinetic and toxicoiogical evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin. J Antimicrob. Chemother. 27(Suppl C):49-61.
38. Wood, C. A., D. R. Norton, S. J. Kohlhepp, P. W. Kohnen, G. A. Porter, D. C. Houghton, R. E. Brummett, W. M. Bennett, and D. N. Gilbert. 1988. The influence of tobramycin dosage regimen on nephrotoxicity, ototoxicity and antibacterial efficacy in a rat model of subcutaneous abscess. J. Infect. Dis 158:13-22.
39. Woodnutt, G., V. Berry, and L. Mizen. 1992. Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections. Antimicrob. Agents Chemother. 36:1427-1431.
40. Woodnutt, G., E. J. Catherall, I. Kernutt, and L. Mizen. 1988 Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum. Antimicrob. Agents Chemother. 32:1705-1719.